FCER1A rs2427837: What Your Genotype Means for IgE
The single nucleotide polymorphism rs2427837 is a common genetic variant situated in the FCER1A gene on chromosome 1q23. FCER1A encodes the alpha chain of the high-affinity immunoglobulin E (IgE) receptor, a central component of allergic immune cascades. Multiple genome-wide association studies link the minor G allele of this variant to statistically significant reductions in total circulating serum IgE concentrations and altered allergic sensitization risk.
What each genotype means
Typical IgE regulation
This genotype is associated with standard baseline levels of total serum IgE. Research indicates that individuals with this profile do not carry the specific genetic variation linked to altered FCER1A expression levels often observed in studies of allergic sensitization.
This is the most common genotype in European populations, where the minor allele frequency is approximately 0.30 to 0.35.
Intermediate IgE regulation
Carrying one copy of the G allele is associated with a measurable influence on total serum IgE levels and FCER1A expression. Studies suggest this variant may modulate the receptor's presence on immune cells, which is a factor in the complex biological pathways of allergic response.
This heterozygous genotype is found in a significant portion of the population, consistent with the reported minor allele frequency of approximately 0.30 to 0.35 in European cohorts.
Altered IgE regulation
This genotype is associated with lower total serum IgE levels compared to the major allele, as the G allele has been identified as a regulatory variant influencing FCER1A expression. While this variant is linked to IgE levels and allergic sensitization risk in large-scale studies, it is one of many genetic and environmental factors that determine an individual's immune response.
This homozygous genotype is less common, occurring in a smaller subset of the population based on the minor allele frequency of approximately 0.30 to 0.35 in European populations.
Genomic Location and Variant Characteristics
The variant rs2427837 is a single nucleotide polymorphism located on chromosome 1q23 within the FCER1A genomic locus. At this position, an individual may carry either the reference A allele or the alternative G allele. While rs2427837 resides in a non-coding region, it exists in very tight linkage disequilibrium with regulatory variants in the nearby FCER1A promoter region, most notably rs2251746. Because these variants are co-inherited together as a conserved haplotype block in many ancestral groups, alleles at rs2427837 serve as an informative genetic marker for altered transcription and gene expression of the FCER1A receptor complex. Genotyping arrays routinely examine rs2427837 to evaluate genetic variation within this key immunoregulatory locus.
Biological Role of the FCER1A Gene
The FCER1A gene provides the genetic blueprint for the alpha subunit of the high-affinity IgE receptor, known as FcεRIα. This surface receptor is expressed predominantly on immune effector cells, including mast cells, basophils, and antigen-presenting dendritic cells. The alpha subunit forms the direct binding pocket for the crystallizable fragment (Fc) region of circulating IgE antibodies. When an allergen binds and cross-links these membrane-bound IgE molecules, it triggers mast cell and basophil degranulation, rapidly releasing histamine, leukotrienes, and inflammatory cytokines that produce allergic symptoms. Furthermore, expression levels of the FcεRI receptor and circulating IgE exist in a dynamic feedback loop, where receptor abundance directly modulates IgE clearance, stabilization, and baseline serum antibody concentrations.
Research Associations and Evidence Strength
Large-scale genome-wide association studies (GWAS) have repeatedly confirmed the association between rs2427837 and baseline total serum IgE levels with genome-wide significance. Pioneering multi-cohort analyses across thousands of participants revealed that each copy of the minor G allele correlates with a roughly 19% to 21% reduction in circulating IgE compared to baseline levels in homozygous A/A individuals. Mechanistic studies have also shown that individuals carrying the G allele display altered cell surface expression of the FcεRI alpha subunit on basophils. While its influence on circulating IgE levels is well-replicated across independent European populations, downstream clinical associations—such as the diagnosis of allergic rhinitis, asthma, or chronic urticaria—show modest or mixed effect sizes across diverse ancestries, highlighting the complex polygenic and environmental architecture of clinical atopy.
Population Frequency and Diversity
The frequency of the rs2427837 variant differs notably across world populations. In individuals of European ancestry, the minor G allele is relatively common, with an estimated minor allele frequency of approximately 0.30 to 0.35, resulting in substantial proportions of heterozygous and homozygous minor carriers. Conversely, allele distributions can vary in non-European ancestries, including East Asian and African populations, where linkage patterns with promoter variants may also differ. Research evaluating FCER1A variants in Han Chinese cohorts, for example, has reported different linkage strengths and varied associations with atopic conditions compared to European studies. These differences underscore why statistical findings from one genetic ancestry cannot automatically be generalized to individuals of different ancestral backgrounds.
Interpretation and Clinical Relevance
Understanding your rs2427837 genotype provides educational insight into baseline immune biology and the regulation of circulating IgE antibodies. However, this variant is an observational marker of a quantitative laboratory trait rather than a diagnostic tool. Carrying alleles associated with lower or higher serum IgE does not guarantee that you will or will not develop allergic rhinitis, asthma, food allergies, or atopic dermatitis. Complex allergic diseases arise from hundreds of genetic loci interacting with childhood microbial exposures, environmental allergens, air quality, and lifestyle factors. Genetic findings for rs2427837 should never be used to initiate, alter, or discontinue allergy medications or biologics without the direct evaluation and guidance of an allergist, immunologist, or qualified healthcare professional.
How common is this variant?
The minor G allele of rs2427837 has an estimated frequency of approximately 0.35 in European populations, where roughly 45% of individuals are heterozygous (AG) and 10% to 15% are homozygous (GG). Frequencies and haplotype structures vary across other global ancestral populations.
Frequently asked questions
What is the rs2427837 variant in the FCER1A gene?
The rs2427837 variant is a common single nucleotide polymorphism located in the FCER1A gene, which codes for the high-affinity IgE receptor alpha subunit. It is well-documented in genetic research for its association with circulating levels of total serum IgE antibodies.
Does having the G allele protect me from getting allergies?
No single genetic variant can prevent allergic disease. While carrying the G allele is statistically associated with lower baseline levels of total serum IgE in large research studies, allergies develop from complex interactions among hundreds of genes and environmental triggers.
How does FCER1A affect how IgE works in the body?
The FCER1A gene encodes the binding component of the high-affinity IgE receptor on cells like mast cells and basophils. This receptor binds IgE molecules, and when allergens bridge those antibodies, it prompts the immune cells to release histamine and other chemicals that drive allergic reactions.
Can this genetic result replace an allergy test from my doctor?
No, DNA genotyping cannot replace clinical allergy evaluations such as skin prick testing or specific allergen IgE blood panels. Your rs2427837 status only reflects a broad statistical predisposition for baseline total IgE and does not measure whether your body produces antibodies against specific allergens.
Does rs2427837 affect my response to allergy medications?
Current clinical guidelines do not use rs2427837 to choose or adjust standard allergy medications, such as antihistamines or corticosteroids. Anyone with questions regarding allergy treatments or biologic therapies should consult an allergist or healthcare provider for evidence-based care.
Sources & further reading
Educational information only, last refreshed 9/5/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs2427837?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FCER1A
Variant in the high-affinity IgE receptor alpha subunit associated with total serum IgE concentrations and allergic sensitization.
Promoter-proximal variant regulating FCER1A transcriptional responsiveness during high-affinity IgE crosslinking on mast cells and basophils.
Regulatory variant in the high-affinity IgE receptor gene FCER1A modulating circulating total IgE concentrations and allergic manifestations.
Variant in the high-affinity IgE receptor alpha subunit locus influencing IgE receptor transcription and susceptibility to atopic allergic sensitization.
Functional FCER1A polymorphism in high linkage disequilibrium with IgE-associated loci that modulates basophil and mast cell IgE receptor expression.